Ozempic savings card: eligibility, terms and price in 2026

Ozempic is semaglutide approved for type 2 diabetes. Novo Nordisk sells it through two price routes: a copay savings card for people whose commercial plan covers Ozempic, and NovoCare Pharmacy self-pay for everyone else. All figures below are as shown on Novo Nordisk pages on Oct 19, 2026, and rechecked on Oct 20, 2026; programs change.

Model your own monthly and yearly spend with the semaglutide cost calculator. For background on the molecule, see the semaglutide hub.

Who qualifies for the Ozempic savings card

The ozempic.com savings page sets the main conditions (Novo Nordisk, Oct 19, 2026):

• Commercial insurance that covers Ozempic. The $25 offer is for commercially insured patients. If your plan does not cover Ozempic, the card does not lower a cash price.
• No government drug coverage. The page says government beneficiaries are excluded. It names Medicare beneficiaries with Part D coverage and people enrolled in federal or state programs such as Medicaid.
• Any pen dose. The offer applies to any dose of the Ozempic pen, for up to a 3-month prescription.
• Time limit. It “provides up to $100 in monthly savings and is valid for up to 48 months.”
• Changes allowed. Novo Nordisk reserves the right to modify or cancel its programs at any time.

How the $25 floor and $100 cap work

The card reduces your copay by up to $100 a month and will not take it below $25. Plans with high copays or a deductible still leave a balance.

These rows are worked examples, not quotes from Novo. Your plan sets the copay; the card only applies the cap and floor. Over 48 months at the $25 floor, the out-of-pocket total would be 48 × $25 = $1,200, if your copay stayed at or under $125 and the program did not change.

Self-pay prices through NovoCare Pharmacy

If your plan does not cover Ozempic, or you have Medicare or Medicaid, the self-pay route applies (Novo Nordisk, Oct 19, 2026):

• New patients pay $199 per month for each of the first two monthly fills of 0.25 mg and 0.5 mg. The offer runs through Dec 31, 2026.
• After that, the price is $349 per month for 0.25, 0.5 or 1 mg and $499 per month for 2 mg.
• One month is one pen box.

The $199 introductory price and $349 standard price trace to November 2025 (Novo Nordisk, Feb 2026). The ozempic.com page notes that self-pay purchases happen outside your insurance plan and cannot be submitted for reimbursement or counted toward your deductible or out-of-pocket limit (Novo Nordisk, Oct 19, 2026).

Which pen each price buys

The Ozempic label lists three 3 mL pens, each tied to specific doses (Novo Nordisk, Jun 1, 2026). The self-pay price follows the dose, so the pen you are prescribed decides the tier.

A 12-month cost example

These totals are our arithmetic on the Oct 19, 2026 self-pay prices. They assume a new patient who follows the label’s minimum steps: 0.25 mg for 4 weeks, then 0.5 mg, with each later increase only if more glycemic control is needed after at least 4 weeks (Novo Nordisk, Jun 1, 2026). A month is treated as one pen box.

The label reserves 2 mg for when additional glycemic control is needed after at least 4 weeks on 1 mg. See the Ozempic dosing schedule for the full ladder, and time the steps with the semaglutide titration calculator.

List price now and in 2027

On Feb 24, 2026, Novo Nordisk announced a list price of $675 per month for Ozempic, Wegovy and Rybelsus, effective Jan 1, 2027 (Novo Nordisk, Feb 24, 2026). The same release says the change does “not have an impact on direct-to-patient, self-pay prices.”

We did not find the current Ozempic list price in dollars on the Novo pages we checked, so we do not state it. A lower list price mainly matters if you pay coinsurance or are in your deductible.

Medicare, Medicaid and Ozempic

• Savings card: not available to Medicare Part D or Medicaid enrollees (Novo Nordisk, Oct 19, 2026).
• Self-pay: available to these patients, outside their plan.
• Spreading costs: the ozempic.com page points Medicare patients to the Medicare Prescription Payment Plan (M3P), as an option for spreading out-of-pocket drug costs.
• Patient assistance: the same page says the NovoCare Patient Assistance Program may provide free Ozempic to eligible patients, with income and U.S. residency requirements.
• The $50 Medicare GLP-1 Bridge described by Novo covers Wegovy injection and pill (Novo Nordisk, Jul 1, 2026). The pages we reviewed do not list Ozempic in it.

Ask your Part D plan how Ozempic is covered for your diagnosis.

Ozempic pill prices

Ozempic.com also lists an Ozempic pill with its own price routes. One month is defined as 1 bottle of 30 tablets (Novo Nordisk, Oct 19, 2026).

Government beneficiaries are excluded from the $25 offer, as with the pen. This guide focuses on the injectable pen; ask your prescriber whether the tablet applies to you.

Ozempic vs Wegovy programs

The two brands are approved for different conditions and are not interchangeable without a new prescription. Compounded semaglutide is a third, separate category: FDA says compounded drugs are not FDA approved (FDA, Apr 1, 2026), and none of these programs apply to them.

Before you enroll

1. Ask your plan whether Ozempic is covered and whether prior authorization applies.
2. If covered, activate the savings card through Novo Nordisk and give the details to your pharmacy.
3. If not covered, compare the self-pay price for your dose with your plan price.
4. Talk to your prescriber before changing dose or brand to fit a price tier.

For the Wegovy version of these terms, see the Wegovy savings card guide. For tirzepatide, see the Mounjaro savings card guide.